NFP
PJP icon

Novak Financial Planning’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Novak Financial Planning’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$470K Hold
5,837
– – 0.23% 91
2021
Q1 		$460K Buy
5,837
+1
+0% +$78 0.25% 85
2020
Q4 		$417K Buy
+5,836
New +$391K 0.25% 83

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Novak Financial Planning's PJP Position: Q2 2021 in Review

Novak Financial Planning held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2021 at 5,837 shares worth $470K. The position accounts for 0.23% of the portfolio, ranked #91.

Novak Financial Planning first reported a position in PJP in Q4 2020 and has held it in 3 quarters since. 90 funds tracked by Wall St. Rank hold PJP as of Q2 2021.

  • Novak Financial Planning held 5,837 shares of Invesco Pharmaceuticals ETF worth $470K as of Q2 2021.
  • Novak Financial Planning left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2021.
  • Invesco Pharmaceuticals ETF made up 0.23% of Novak Financial Planning's portfolio in Q2 2021, its #91 holding.
  • Novak Financial Planning first reported a position in Invesco Pharmaceuticals ETF in Q4 2020 and has held it in 3 quarters since.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2021.

Based on Novak Financial Planning's 13F filing for Q2 2021, filed 21 Jul 2021.